Filing Details
- Accession Number:
- 0001562180-21-005871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-08 16:08:16
- Reporting Period:
- 2021-09-03
- Accepted Time:
- 2021-09-08 16:08:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1636422 | Health Catalyst Inc. | HCAT | Services-Computer Programming, Data Processing, Etc. (7370) | 453337483 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780878 | Linda Llewelyn | C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095 | Chief People Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-03 | 1,100 | $11.78 | 36,736 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-09-03 | 1,100 | $10.80 | 37,836 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-09-03 | 3,179 | $54.27 | 34,657 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-03 | 1,100 | $0.00 | 1,100 | $11.78 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-03 | 1,100 | $0.00 | 1,100 | $10.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,254 | 2028-01-24 | No | 4 | M | Direct | |
27,748 | 2028-09-27 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
- Represents the weighted average sale price of the shares sold ranging from $53.86 to $54.66 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote.
- 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
- 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.